IRIS Accounts Production v25.2.0.378 09261020 Board of Directors 1.1.24 31.12.24 31.12.24 true false true false false true false A ORDINARY 1.00000 B ORDINARY 1.00000 AO ORDINARY 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092610202023-12-31092610202024-12-31092610202024-01-012024-12-31092610202022-12-31092610202023-01-012023-12-31092610202023-12-3109261020ns15:EnglandWales2024-01-012024-12-3109261020ns14:PoundSterling2024-01-012024-12-3109261020ns10:Director12024-01-012024-12-3109261020ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3109261020ns10:SmallEntities2024-01-012024-12-3109261020ns10:AuditExemptWithAccountantsReport2024-01-012024-12-3109261020ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3109261020ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3109261020ns10:FullAccounts2024-01-012024-12-3109261020ns10:OrdinaryShareClass12024-01-012024-12-3109261020ns10:OrdinaryShareClass22024-01-012024-12-3109261020ns10:OrdinaryShareClass32024-01-012024-12-3109261020ns10:Director22024-01-012024-12-3109261020ns10:RegisteredOffice2024-01-012024-12-3109261020ns5:CurrentFinancialInstruments2024-12-3109261020ns5:CurrentFinancialInstruments2023-12-3109261020ns5:Non-currentFinancialInstruments2024-12-3109261020ns5:Non-currentFinancialInstruments2023-12-3109261020ns5:ShareCapital2024-12-3109261020ns5:ShareCapital2023-12-3109261020ns5:SharePremium2024-12-3109261020ns5:SharePremium2023-12-3109261020ns5:FurtherSpecificReserve1ComponentTotalEquity2024-12-3109261020ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-3109261020ns5:RetainedEarningsAccumulatedLosses2024-12-3109261020ns5:RetainedEarningsAccumulatedLosses2023-12-3109261020ns5:FurnitureFittings2023-12-3109261020ns5:FurnitureFittings2024-01-012024-12-3109261020ns5:FurnitureFittings2024-12-3109261020ns5:FurnitureFittings2023-12-3109261020ns5:CostValuation2023-12-3109261020ns5:Subsidiary12024-01-012024-12-31092610201ns5:Subsidiary12024-01-012024-12-3109261020ns5:Subsidiary12024-12-3109261020ns5:Subsidiary12023-12-3109261020ns5:Subsidiary12023-12-3109261020ns5:Subsidiary12023-01-012023-12-3109261020ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3109261020ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3109261020ns10:OrdinaryShareClass12024-12-3109261020ns10:OrdinaryShareClass22024-12-3109261020ns10:OrdinaryShareClass32024-12-31
REGISTERED NUMBER: 09261020 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

HEALUM LTD

HEALUM LTD (REGISTERED NUMBER: 09261020)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 9

HEALUM LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: Mr J Abraham
Mr A Saboo





REGISTERED OFFICE: 28 Mason Street
Manchester
M4 5EY





REGISTERED NUMBER: 09261020 (England and Wales)





ACCOUNTANTS: Dunhams
Chartered Accountants
11 Warwick Road
Old Trafford
Stretford
Manchester
M16 0QQ

HEALUM LTD (REGISTERED NUMBER: 09261020)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,635 2,818
Investments 5 100 100
1,735 2,918

CURRENT ASSETS
Debtors 6 51,170 125,014
Cash at bank 110,971 42,045
162,141 167,059
CREDITORS
Amounts falling due within one year 7 (75,380 ) (145,695 )
NET CURRENT ASSETS 86,761 21,364
TOTAL ASSETS LESS CURRENT LIABILITIES 88,496 24,282

CREDITORS
Amounts falling due after more than one
year

8

(320,084

)

-
NET (LIABILITIES)/ASSETS (231,588 ) 24,282

CAPITAL AND RESERVES
Called up share capital 9 52,497 52,497
Share premium 1,140,525 1,140,525
Loan note equity element 16,446 -
Retained earnings (1,441,056 ) (1,168,740 )
SHAREHOLDERS' FUNDS (231,588 ) 24,282

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

HEALUM LTD (REGISTERED NUMBER: 09261020)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 April 2025 and were signed on its behalf by:





Mr J Abraham - Director


HEALUM LTD (REGISTERED NUMBER: 09261020)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Healum Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


The financial statements are presented rounded to the nearest Pound Sterling.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period or in the period of the revision and future periods where the revision affects both current and future periods. No critical judgements or estimates have been made by the directors in preparing these financial statements

Turnover
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25%

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

HEALUM LTD (REGISTERED NUMBER: 09261020)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment.

Debtors and creditors that fall due within one year are recorded in the financial statements at transaction price and then subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors).

Debtors are reviewed for impairment at each reporting date and any impairments are recorded within profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt. Debtors do not carry interest and are stated at their nominal value.

Trade creditors are not interest-bearing and are stated at their nominal value. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.


All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.


The liability component of a compound financial instruments is initially recognised at the fair value of a similar liability that does not have an equity conversion option. The equity component is initially recognised at the difference between the fair value of the compound financial instrument as a whole and the fair value of the liability component. Any directly attributable transaction costs are allocated to the liability and equity components in proportion to their initial carrying amounts. Subsequent to initial recognition, the liability component of a compound financial instrument is measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

HEALUM LTD (REGISTERED NUMBER: 09261020)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 8 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 January 2024 5,528
Additions 274
At 31 December 2024 5,802
DEPRECIATION
At 1 January 2024 2,710
Charge for year 1,457
At 31 December 2024 4,167
NET BOOK VALUE
At 31 December 2024 1,635
At 31 December 2023 2,818

5. FIXED ASSET INVESTMENTS
Shares in
group
undertaking
£   
COST
At 1 January 2024
and 31 December 2024 100
NET BOOK VALUE
At 31 December 2024 100
At 31 December 2023 100

HEALUM LTD (REGISTERED NUMBER: 09261020)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

5. FIXED ASSET INVESTMENTS - continued

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Healum (India) Private Ltd
Registered office: HD-255, WeWork Enam Sambhav c20, G Block Rd, G Block BKC, Bandra (E), Mumbai 400051
Nature of business: Dormant
%
Class of shares: holding
Ordinary 99.99
31.3.24 31.3.22
£    £   
Aggregate capital and reserves (301 ) (48 )
Loss for the year (256 ) (148 )

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 58 69,390
Other debtors - 343
Directors' current accounts 26 -
Tax 40,000 45,851
VAT 1,656 -
Prepayments and accrued income 9,430 9,430
51,170 125,014

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 28,321 43,334
Social security and other taxes 5,239 12,095
Pension control - 1,060
VAT - 5,894
Accrued expenses 33,746 25,487
Deferred income 8,074 57,825
75,380 145,695

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Convertible loan notes 320,084 -

HEALUM LTD (REGISTERED NUMBER: 09261020)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
37,176 A ORDINARY 1 37,178 37,178
7,140 B ORDINARY 1 7,140 7,140
8,178 AO ORDINARY 1 8,179 8,179
52,497 52,497

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
HEALUM LTD

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Healum Ltd for the year ended 31 December 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Healum Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Healum Ltd and state those matters that we have agreed to state to the Board of Directors of Healum Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Healum Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Healum Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Healum Ltd. You consider that Healum Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Healum Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Dunhams
Chartered Accountants
11 Warwick Road
Old Trafford
Stretford
Manchester
M16 0QQ


11 April 2025